A Prospective Observational Study on Establishment of New Biomarkers to Compensate for Peritoneal Lavage Cytology in Pancreatic Cancer
Not Applicable
Recruiting
- Conditions
- Pancreatic Ductal Adenocarcinoma
- Registration Number
- JPRN-UMIN000045828
- Lead Sponsor
- Department of Surgery, National Hospital Organization Nagoya Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 180
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients with serious comorbidities (2) Patients with active multiple cancers (3) Patients with mental disease interfering taking part in the trial (4) Pregnant or breast-feeding women, or women suspected of being pregnant (5) Patients who are judged unsuitable for the study by the principal investigator or sub-investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prognostic impact of new biomarkers on disease-free survival
- Secondary Outcome Measures
Name Time Method